Evaluation of therapy effect of 131Ⅰ treatment of nasopharyngeal carcinoma xenograft mediated by hNIS gene transfection in vivo using diffusion weighted MR

( views:446, downloads:0 )
Author:
ZHONG Xing(Department of Medical Imaging and Nuclear Medicine, Institute of Molecular Imaging, Jinan University, Guangzhou 510630, China)
SHI Chang-zheng(Department of Medical Imaging and Nuclear Medicine, Institute of Molecular Imaging, Jinan University, Guangzhou 510630, China)
GONG Jian(Department of Medical Imaging and Nuclear Medicine, Institute of Molecular Imaging, Jinan University, Guangzhou 510630, China)
GUO Bin(Department of Medical Imaging and Nuclear Medicine, Institute of Molecular Imaging, Jinan University, Guangzhou 510630, China)
HUANG Li(Department of Medical Imaging and Nuclear Medicine, Institute of Molecular Imaging, Jinan University, Guangzhou 510630, China)
XU Hao(Department of Medical Imaging and Nuclear Medicine, Institute of Molecular Imaging, Jinan University, Guangzhou 510630, China)
Journal Title:
Chinese Journal of Radiology
Issue:
Volume 46, Issue 10, 2012
DOI:
10.3760/cma.j.issn.1005-1201.2012.10.015
Key Word:
Diffusion magnetic resonance imaging; Nasopharyngeal neoplasms; Iodine; Radioisotopes

Abstract: Objective To investigate the imaging characteristic of DW1,tumor cell apoptosis and proliferation of nasopharyngeal carcinoma (NPC) xenograft transfected hNIS gene after 131Ⅰ treatment.Methods The NPC xenograft models were established with CNE-2-hNIS cells(experimental group) and CNE-2 cells(control group) respectively.After i.p.injections 131Ⅰ in the experimental group and control group,the changes of xenograft tumor volume and ADC value were observed in 3,6,12,18,24 days by MR scan.The correlations of changes of ADC with pathological TUNEL,Caspase-3 immunohistochemistry of apoptosis,and Ki-67 proliferation detection were further investigated.Independent samples t-test were compared between the two groups and Pearson linear correlation analysis was used.Results The tumor volume of the experimental group was significantly reduced compared with that of the control group after 131 Ⅰ treatment (t values:8.27-19.46,P <0.05 ).DW-MRI showed that in the 3th day after 131Ⅰ treatment,ADC values increased in the experimental group,and ADC values reached the peak in the 6th and 12th day after 131Ⅰ treatment,then ADC values were decreased. ADC values after treatment was positively correlated with apoptotic index ( r =0.72,P < 0.05 ) and caspase-3 positive rate ( r =0.65,P < 0.05) and there was a negative correlation with Ki-67 proliferation index ( r =- 0.71,P < 0.05 ).Conclusion ADC values can reflect growth inhibition of NPC xenograft transfected hNIS gene after 131 I treatment.It is possible that DWMRI techniques can be used in early non-invasively monitor the therapy effect of 131Ⅰ treatment of NPC xenografts transfected hNIS gene.

  • [1]Riesco-Eizaguirre G,Saotisteban P.A perspective view of sodium iodide symporter research and its clinical implications.Eur J Endocrinol,2006,155:495-512.
  • [2]钟兴,弓健,曾祥凤,等.hNIS转基因介导131碘对鼻咽癌细胞增殖和凋亡的影响.暨南大学学报:自然科学与医学版,2010,31:387-392.
  • [3]Eisenhauera EA,Therasseb P,Bogaertsc J,et al.New response evaluation criteria in solid tumours:revised RECIST guideline (version 1.1).Eur J Cancer,2009,45:228-247.
  • [4]Charles-Edwards EM,deSouza NM. Diffusion-weighted magnetic resonance imaging and its application to cancer.Cancer Imaging,2006,6:135-143.
  • [5]Pickles MD,Gibbs P,Lowry M,et al.Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer.Magn Reson Imaging,2006,24:843-847.
  • [6]江新青,刘真,魏新华,等.兔VX2肝癌放疗后的MR扩散加权成像特征与细胞凋亡情况.中华放射学杂志,2010,44:540-544.
  • [7]Spitzweg C,O' Connor MK,Bergert ER,et al.Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter.Cancer Res,2000,60:6526-6530.
  • [8]Kim H,Morgan DE,Zeng H,et al.Breast tumor xenografts:diffusion-weighted MR imaging to assess early therapy with novel apoptosis-inducing anti-DR5 antibody.Radiology,2008,248:844-851.
  • [9]Hamstra DA, Rehemtulla A, Ross BD. Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology.J Clin Oncol,2007,25:4104-4109.
  • [10]Mardor Y,Roth Y,Ochershvilli A,et al.Pretreatment prediction of brain tumors response to radiation therapy using high b-value diffusion-weighted MRI.Neoplasia,2004,6:136-142.
  • [11]Kauppinen RA.Monitoring cytotoxic tumour treatment response by diffusion magnetic resonance and proton spectroscopy.NMR Biomed,2002,15:6-17.
  • [12]Humphries PD,Sebire NJ,Siegel MJ,et al.Tumors in pediatric patients at diffusion-weighted MR imaging:apparent diffusion coefficient and tumor cellularity.Radiology,2007,245:848-854.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn